These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 17909914)
21. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody and cytological detection of free malignant cells in the peritoneal cavity during resection of colorectal cancer--can monoclonal antibodies do better? Ambrose NS; MacDonald F; Young J; Thompson H; Keighley MR Eur J Surg Oncol; 1989 Apr; 15(2):99-102. PubMed ID: 2649397 [TBL] [Abstract][Full Text] [Related]
23. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108 [TBL] [Abstract][Full Text] [Related]
25. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
26. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822 [TBL] [Abstract][Full Text] [Related]
27. Perioperative detection of disseminated tumour cells is an independent prognostic factor in patients with colorectal cancer. Bosch B; Guller U; Schnider A; Maurer R; Harder F; Metzger U; Marti WR Br J Surg; 2003 Jul; 90(7):882-8. PubMed ID: 12854118 [TBL] [Abstract][Full Text] [Related]
28. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection. Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Kobayashi H; Mochizuki H; Sugihara K; Morita T; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hase K; Oya M; Maeda K; Hirai T; Kameyama M; Shirouzu K; Muto T Surgery; 2007 Jan; 141(1):67-75. PubMed ID: 17188169 [TBL] [Abstract][Full Text] [Related]
30. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma. Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299 [TBL] [Abstract][Full Text] [Related]
31. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer. Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639 [TBL] [Abstract][Full Text] [Related]
32. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer. Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195 [TBL] [Abstract][Full Text] [Related]
34. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
35. Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients. Hayama T; Iinuma H; Watanabe T Oncol Rep; 2007 Oct; 18(4):779-84. PubMed ID: 17786336 [TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC; Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296 [TBL] [Abstract][Full Text] [Related]
37. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927 [TBL] [Abstract][Full Text] [Related]
38. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699 [TBL] [Abstract][Full Text] [Related]
39. The impact of anastomotic leak and intra-abdominal abscess on cancer-related outcomes after resection for colorectal cancer: a case control study. Eberhardt JM; Kiran RP; Lavery IC Dis Colon Rectum; 2009 Mar; 52(3):380-6. PubMed ID: 19333035 [TBL] [Abstract][Full Text] [Related]
40. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]